LNSR
LENSARCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-07-22
Current thesis
The operating backdrop is better than a typical busted-deal micro-cap: March 31 disclosures showed continued ALLY placements, a larger installed base, 22% annual procedure growth, and recurring revenue at 79% of sales, while the company kept the $10 million merger deposit and added a sizable credit facility [#PR-2026-03-31] [#8-K-2026-03-16] [#8-K-2026-03-12].
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
ALLY placements or procedure growth may slow once the company operates fully on a standalone basis
Momentum
68
Value
37
Sentiment
55
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.60 · Bull $8.50 · Bear $3.60
Data freshness
Prices
As of 2026-07-22
Fundamentals
As of 2026-07-22 • Vendor: Data Vendor v1
Scores
As of 2026-07-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-17 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-22
Investment thesis
As of 2026-07-22
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $8.50
Why
Momentum68 · Δ7d -
Value37 · Δ7d +0.0
Sentiment55 · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Sentiment · See AI snapshot
Momentum
68
26% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
39% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.1
Sentiment
55
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 67.9 / Value 36.5 / Sentiment 54.8
Fundamentals (TTM)As of 2026-07-22
Fundamentals (TTM)
As of 2026-07-22
Market Cap
$69.6M
Beta
0.69
Shares Out
12.1M
P/E (TTM) · Derived
-2.0
P/S (TTM)
2.27
P/FCF (TTM) · Derived
-6.10
Rev YoY
-5.2%
EPS YoY
-100.1%
Gross Margin
+44.1%
Op Margin
-35.4%
Net Debt
-$15.24M
Current Ratio
2.38
As of 2026-07-22 • Updated nightlySource: Internal modelMethodology